To analyze the effects of transumbilical laparoendoscopic single site surgery(LESS) combined with dexmedetomidine in the treatment of congenital intestinal atresia(CIA) on intestinal function, serum neuron-specific enolase(NSE) level, growth hormone(GH), insulin-like growth factor binding protein(IGFBP)-3 and markers of intestinal barrier function.
A total of 206 newborns with CIA admitted to our hospital from June 2022 to June 2024 were selected as the study objects and randomly divided into observation group and control group, with 103 cases in each group. The control group received LESS, and the observation group was treated with dexmedetomidine on the basis of control group. The time of indwelling gastric tube, first exhaust time, the incidence of complications and intestinal function recovery were compared between the two groups after surgery.
The incidence of intestinal obstruction, anastomotic impotence, diarrhea and other complications in the observation group was lower than that in the control group(P<0.05), and the time of indwelling gastric tube and first exhaust time were shorter than those in the control group(P<0.05). The levels of total protein, albumin and hemoglobin in the observation group were significantly better than those in the control group(P<0.05). The refeeding time and the whole feeding time of the observation group were shorter than those of the control group(P<0.05). The improvement of serum NSE in the observation group was better than that in the control group(P<0.05), and the levels of GH and IGFBP-3 were higher than those in the control group(P<0.05). The levels of intestinal barrier function markers in the observation group were higher than those in the control group, and the intestinal permeability was significantly improved compared with the control group(P<0.05).
LESS combined with dexmedetomidine can reduce the incidence of complications after CIA, shorten the postoperative recovery time, improve enteral nutrition, regulate serum NSE level, promote the level of GH and IGFBP-3, and improve intestinal barrier function, which has certain clinical value.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |